Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: A report of four cases and a systematic review of the literature

Mischelle A. Elliott, John A. Heit, Rajiv K. Pruthi, Dennis A. Gastineau, Jeffrey L. Winters, C. Christopher Hook

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: A report of four cases and a systematic review of the literature'. Together they form a unique fingerprint.

Medicine & Life Sciences